Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life setting
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | EJC Skin Cancer |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772611824002246 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846159034912079872 |
|---|---|
| author | I. Ciobotariu A. Di Stefani A. Paradisi L. Di Nardo K. Peris |
| author_facet | I. Ciobotariu A. Di Stefani A. Paradisi L. Di Nardo K. Peris |
| author_sort | I. Ciobotariu |
| collection | DOAJ |
| format | Article |
| id | doaj-art-7a19caa3df7a4a3ba94e980e1f3d009a |
| institution | Kabale University |
| issn | 2772-6118 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | EJC Skin Cancer |
| spelling | doaj-art-7a19caa3df7a4a3ba94e980e1f3d009a2024-11-24T04:15:21ZengElsevierEJC Skin Cancer2772-61182024-01-012100236Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life settingI. Ciobotariu0A. Di Stefani1A. Paradisi2L. Di Nardo3K. Peris4Fondazione Policlinico Universitario A. Gemelli - IRCCS, UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Rome, ItalyFondazione Policlinico Universitario A. Gemelli - IRCCS, UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Rome, ItalyFondazione Policlinico Universitario A. Gemelli - IRCCS, UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Rome, ItalyFondazione Policlinico Universitario A. Gemelli - IRCCS, UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Rome, ItalyFondazione Policlinico Universitario A. Gemelli - IRCCS, UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Rome, Italyhttp://www.sciencedirect.com/science/article/pii/S2772611824002246 |
| spellingShingle | I. Ciobotariu A. Di Stefani A. Paradisi L. Di Nardo K. Peris Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life setting EJC Skin Cancer |
| title | Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life setting |
| title_full | Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life setting |
| title_fullStr | Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life setting |
| title_full_unstemmed | Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life setting |
| title_short | Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life setting |
| title_sort | neutrophil lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to cemiplimab treatment a real life setting |
| url | http://www.sciencedirect.com/science/article/pii/S2772611824002246 |
| work_keys_str_mv | AT iciobotariu neutrophillymphocyteratioasapredictivemarkerforprogressionfreesurvivalinpatientswithadvancedcutaneoussquamouscellcarcinomapriortocemiplimabtreatmentareallifesetting AT adistefani neutrophillymphocyteratioasapredictivemarkerforprogressionfreesurvivalinpatientswithadvancedcutaneoussquamouscellcarcinomapriortocemiplimabtreatmentareallifesetting AT aparadisi neutrophillymphocyteratioasapredictivemarkerforprogressionfreesurvivalinpatientswithadvancedcutaneoussquamouscellcarcinomapriortocemiplimabtreatmentareallifesetting AT ldinardo neutrophillymphocyteratioasapredictivemarkerforprogressionfreesurvivalinpatientswithadvancedcutaneoussquamouscellcarcinomapriortocemiplimabtreatmentareallifesetting AT kperis neutrophillymphocyteratioasapredictivemarkerforprogressionfreesurvivalinpatientswithadvancedcutaneoussquamouscellcarcinomapriortocemiplimabtreatmentareallifesetting |